(Q82413237)
Statements
MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: a multicenter, randomized, placebo-controlled phase IIb study (English)
Abraham Adunsky
Julie Chandler
Norman Heyden
Jeannine Lutkiewicz
Boyd B Scott
Yuliya Berd
Nancy Liu
Dimitris A Papanicolaou